A Scottish health board has become the fourth to adopt a data-driven technology platform designed to optimise the efficiencies of operating theatres.
NHS Lanarkshire has joined the growing list of customers using the Infix Support software, which is aimed at reducing hospital waiting times and speeding up the patient pathway nationwide.
NHS Lothian, NHS Forth Valley, and NHS Highland have all implemented the platform – with the remaining health boards to follow over the next twelve months.
Infix has just started implementation at NHS Borders, with NHS Greater Glasgow and Clyde, and Golden Jubilee National Hospital lined up next.
Dr Matthew Freer, CEO and founder of Infix, said: “We’re so grateful for all the support and hard work put in to make NHS Lanarkshire such a successful transition, from Lanarkshire’s Digital team led by Donald Wilson, the outgoing CEO Jann Gardner, and the clinical teams working across the region.”
Jann Gardner, former Chief Executive of NHS Lanarkshire and recently appointed CEO of Greater Glasgow and Clyde, said: “Infix’s innovative approach to improving operating theatre efficiency is a significant step forward in helping us enhance theatre performance and reduce waiting times.
“By optimising the use of our resources, this data-driven solution is already making a real difference for patients in NHS Lanarkshire, and I look forward to seeing its impact continue to grow across NHS Scotland.”
Infix’s technology improves operating theatre efficiency by up to 20 per cent, and the team are currently layering in more advanced AI to further enhance the solution.
Dr Freer said: “With the vast quantities of data and use cases we’ve gathered over the last few years, we have been able to target the precise areas where AI can add even more value”.
Infix is set to announce its latest external investment round next month, with CEO Freer saying that the focus remains on Scotland but also setting Infix’s sights on increasing opportunities in the rest of the UK and internationally.
He added: “While ramping up Infix in Scotland is our main priority this year, we’re now also actively engaging with NHS England, and we’ve also seen high levels of interest from the Middle East, where we recently attended the Arab Health conference in Dubai and pitched to one of the world’s largest hospital and care groups.”
Infix has also grown its executive and non-executive teams, with former Current Health clinical operations manager Sarah Marsh joining as Chief Clinical Officer, and David Bowerman, former COO at Tesco Bank and Managing Director at RBS, joining Infix’s Board.
Dr Freer said: “We’re excited to have Sarah and David on the team. Sarah brings high-level clinical experience gained at one of Europe’s most successful healthcare technology companies, and David brings extensive experience in implementing large scale technology change during his financial services career.”